tert-Butyl 4-((6-chloropyridazin-3-yl)sulfonyl)piperazine-1-carboxylate
97%
- Product Code: 46038
CAS:
2368870-27-1
| Molecular Weight: | 362.8324 g./mol | Molecular Formula: | C₁₃H₁₉ClN₄O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD32069578 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. It is often employed in the creation of potential drug candidates targeting various diseases, particularly those involving enzyme inhibition or receptor modulation. Its structure, featuring a piperazine core and a chloropyridazine moiety, makes it valuable for designing compounds with specific binding properties. Researchers leverage its sulfonyl and carboxylate functional groups to enhance solubility and bioavailability in drug formulations. Additionally, it is used in medicinal chemistry studies to explore structure-activity relationships (SAR) for optimizing therapeutic efficacy and reducing side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €365.18 |
+
-
|
tert-Butyl 4-((6-chloropyridazin-3-yl)sulfonyl)piperazine-1-carboxylate
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active molecules. It is often employed in the creation of potential drug candidates targeting various diseases, particularly those involving enzyme inhibition or receptor modulation. Its structure, featuring a piperazine core and a chloropyridazine moiety, makes it valuable for designing compounds with specific binding properties. Researchers leverage its sulfonyl and carboxylate functional groups to enhance solubility and bioavailability in drug formulations. Additionally, it is used in medicinal chemistry studies to explore structure-activity relationships (SAR) for optimizing therapeutic efficacy and reducing side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :